PCN89 COST-EFFECTIVENESS OF NIVOLUMAB AS ADJUVANT TREATMENT OF MELANOMA IN ADULTS WITH INVOLVEMENT OF LYMPH NODES OR METASTATIC DISEASE WHO HAVE UNDERGONE COMPLETE RESECTION IN BELGIUM

Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.286
https://www.valueinhealthjournal.com/article/S1098-3015(19)32664-6/fulltext
Title : PCN89 COST-EFFECTIVENESS OF NIVOLUMAB AS ADJUVANT TREATMENT OF MELANOMA IN ADULTS WITH INVOLVEMENT OF LYMPH NODES OR METASTATIC DISEASE WHO HAVE UNDERGONE COMPLETE RESECTION IN BELGIUM
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32664-6&doi=10.1016/j.jval.2019.09.286
First page :
Section Title :
Open access? : No
Section Order : 10229
Categories :
Tags :
Regions :
ViH Article Tags :